Reactive oxygen species Reactive nitrogen species Brain Lipid/protein modification Aerobes require oxygen for metabolism and normal free radical formation. As a result, maintaining the redox homeostasis is essential for brain cell survival due to their high metabolic energy requirement to sustain electrochemical gradients, neurotransmitter release, and membrane lipid stability. Further, brain antioxidant levels are limited compared to other organs and less able to compensate for reactive oxygen and nitrogen species (ROS/RNS) generation which contribute oxidative/nitrative stress (OS/NS). Antioxidant treatments such as vitamin E, minocycline, and resveratrol mediate neuroprotection by prolonging the incidence of or reversing OS and NS conditions. Redox imbalance occurs when the antioxidant capacity is overwhelmed, consequently leading to activation of alternate pathways that remain quiescent under normal conditions. If OS/NS fails to lead to adaptation, tissue damage and injury ensue, resulting in cell death and/or disease. The progression of OS/NS-mediated neurodegeneration along with contributions from microglial activation, dopamine metabolism, and diabetes comprise a detailed interconnected pathway. This review proposes a significant role for OS/NS and more specifically, lipid peroxidation (LPO) and other lipid modifications, by triggering microglial activation to elicit a neuroinflammatory state potentiated by diabetes or abnormal dopamine metabolism. Subsequently, sustained stress in the neuroinflammatory state overwhelms cellular defenses and prompts neurotoxicity resulting in the onset or amplification of brain damage.
, hydrogen peroxide; ROS, reactive oxygen species; RNS, reactive nitrogen species; XO, xanthine oxidase; NOX, NADPH oxidase; SOD, superoxide dismutase; CAT, catalase; GPx, glutathione peroxidase; GSH, reduced glutathione; GSSG, oxidized glutathione; NOS, nitric oxide synthase; nNOS, neuronal nitric oxide synthase; iNOS, inducible nitric oxide synthase; eNOS, endothelial nitric oxide synthase; FMN, flavin mononucleotide; FAD, flavin adenine dinucleotide; BH 4 , tetrahydrobiopterin; PUFA, polyunsaturated fatty acid; LPO, lipid peroxidation; 4-HNE, 4-hydroxy-2-nonenal; MDA, malondialdehyde; TBARS, thiobarbituric acid reacting substance; 3-NT, protein tyrosine nitration; SNO, S-nitrosylation; NO 2 -FA, nitrated fatty acid; HO-1, heme oxygenase-1; NF-kB, nuclear factor kappa light chain enhancer of activated B cells; PPAR, peroxisome proliferator-activated receptor;
• NO 2 , nitrogen dioxide radical; NO 2 + , nitronium ion; CNS, central nervous system; MGLA, microglial activation; DQ, dopamine-quinones; DA, dopamine; ACh, acetylcholine; T2IDDM, type II insulin-dependent diabetes mellitus; PDN, peripheral diabetic neuropathy; HD, Huntington's disease; AD, Alzheimer's disease; NDD, neurodegenerative disease; PD, Parkinson's disease; MS, multiple sclerosis; LYSD, lysosomal storage diseases; HIV, human immunodeficiency virus; TBI, traumatic brain injury; Htt, huntingtin protein; mHtt, mutant huntingtin protein; KA, kainic acid; QUIN, quinolinic acid; 3-NP, 3-nitropropionic acid; Lcar, L-carnitine; APP, Alzheimer's precursor protein; Aβ, toxic amyloid beta peptide fragments; PARP1, poly-ADP-ribose polymerase-1; NA, nicotinamide; AChE, acetylcholinesterases; MA, methamphetamine; NAC, N-acetylcysteine; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D-PUFA, deuterated polyunsaturated fatty acid; H 2 S, hydrogen sulfide; 6-OHDA, 6-hydroxydopamine; Rot, rotenone; ApoD, apolipoprotein D; PQ, paraquat; LPS, lipopolysaccharide; SSRI, selective serotonin reuptake inhibitor; XIAP, X-linked inhibitors of apoptosis; CSF, cerebrospinal fluid; NfH [Sm135], neurofilament heavy chain; GEPR, genetically epileptic prone rat; LA, lipoic acid; PIC, pilocarpine; SAM-P8, senescence accelerated mouse prone; SAM-R1, senescence accelerated mouse resistant; IR, ischemia/reperfusion; p75, p75 neutrotrophin receptor; STZ, streptozotocin; TrkA, tyrosine kinase receptor A; NGF, nerve growth factor; ob/ob, leptin-deficient mice; IOP, intraocular pressure; ALA, α-lipoic acid; MPS, mucopolysaccharoidosis IIIB; AIDS, acquired immunodeficiency syndrome; SIV, simian immunodeficiency virus; MAO, monoamine oxidase; BBB, blood brain barrier; PDI, protein disulfide isomerase; NMDAr, N-methyl-D-aspartate receptor; TH, tyrosine hydroxylase; ALS, amyotrophic lateral sclerosis.
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